Siegel RL, Miller KD, Fuchs HE, Jemal A. Most cancers statistics, 2022. CA Most cancers J Clin. 2022;72:7–33.
Akbari A, Nazari-Khanamiri F, Ahmadi M, Shoaran M, Rezaie J. Engineered exosomes for tumor-targeted drug supply: a give attention to genetic and chemical functionalization. Pharmaceutics. 2022;15:78.
Ngoune R, Peters A, von Elverfeldt D, Winkler Okay, Pütz G. Accumulating nanoparticles by EPR: A route of no return. J Management Launch. 2016;238:58–70.
Li H, Wu Z, Zhang J, Solar X, Duan F, Yao J, Solar M, Zhang J, Nie L. Immediate ultrasound-evoked exact nanobubble explosion and deep photodynamic remedy for tumors guided by molecular imaging. ACS Appl Mater Interfaces. 2021;13:21097–107.
Chen R, Huang S, Lin T, Ma H, Shan W, Duan F, Lv J, Zhang J, Ren L, Nie L. Photoacoustic molecular imaging-escorted adipose photodynamic-browning synergy for preventing weight problems with virus-like complexes. Nat Nanotechnol. 2021;16:455–65.
Joseph TM, Kar Mahapatra D, Esmaeili A, Piszczyk Ł, Hasanin MS, Kattali M, Haponiuk J, Thomas S. Nanoparticles: taking a singular place in drugs. Nanomaterials (Basel). 2023;13:78.
Kim H, Kim EH, Kwak G, Chi SG, Kim SH, Yang Y. Exosomes: cell-derived nanoplatforms for the supply of most cancers therapeutics. Int J Mol Sci. 2020;22:67.
Arrighetti N, Corbo C, Evangelopoulos M, Pastò A, Zuco V, Tasciotti E. Exosome-like nanovectors for drug supply in most cancers. Curr Med Chem. 2019;26:6132–48.
Pathan M, Fonseka P, Chitti SV, Kang T, Sanwlani R, Van Deun J, Hendrix A, Mathivanan S. Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res. 2019;47:D516-d519.
Wiklander OPB, Brennan M, Lötvall J, Breakefield XO, El Andaloussi S. Advances in therapeutic functions of extracellular vesicles. Sci Transl Med. 2019;11:54.
Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, Fang X, Zhang X. Exosomes as a brand new frontier of most cancers liquid biopsy. Mol Most cancers. 2022;21:56.
Kalluri R, LeBleu VS. The biology, operate, and biomedical functions of exosomes. Science. 2020;367:67.
Ginini L, Billan S, Fridman E, Gil Z. Perception into extracellular vesicle-cell communication: from cell recognition to intracellular destiny. Cells. 2022;11:78.
Lin S, Yu Z, Chen D, Wang Z, Miao J, Li Q, Zhang D, Tune J, Cui D. Progress in microfluidics-based exosome separation and detection applied sciences for diagnostic functions. Small. 2020;16: e1903916.
Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and different extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–89.
Buratta S, Tancini B, Sagini Okay, Delo F, Chiaradia E, Urbanelli L, Emiliani C. Lysosomal Exocytosis, Exosome Launch and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Techniques Go Extracellular. Int J Mol Sci. 2020;21:78.
Chen J, Li P, Zhang T, Xu Z, Huang X, Wang R, Du L. Evaluation on methods and applied sciences for exosome isolation and purification. Entrance Bioeng Biotechnol. 2021;9: 811971.
Dixson AC, Dawson TR, Di Vizio D, Weaver AM. Context-specific regulation of extracellular vesicle biogenesis and cargo choice. Nat Rev Mol Cell Biol. 2023;24:454.
Katzmann DJ, Stefan CJ, Babst M, Emr SD. Vps27 recruits ESCRT equipment to endosomes throughout MVB sorting. J Cell Biol. 2003;162:413–23.
Nickerson DP, Russell MR, Odorizzi G. A concentric circle mannequin of multivesicular physique cargo sorting. EMBO Rep. 2007;8:644–50.
Hurley JH, Emr SD. The ESCRT complexes: construction and mechanism of a membrane-trafficking community. Annu Rev Biophys Biomol Struct. 2006;35:277–98.
Tschuschke M, Kocherova I, Bryja A, Mozdziak P, Angelova Volponi A, Janowicz Okay, Sibiak R, Piotrowska-Kempisty H, Iżycki D, Bukowska D, et al. Inclusion biogenesis, strategies of isolation and medical software of human mobile exosomes. J Clin Med. 2020;9:34.
Trajkovic Okay, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B, Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319:1244–7.
Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-mediated metastasis: communication from a distance. Dev Cell. 2019;49:347–60.
Lässer C, Shelke GV, Yeri A, Kim DK, Crescitelli R, Raimondo S, Sjöstrand M, Gho YS, Van Keuren JK, Lötvall J. Two distinct extracellular RNA signatures launched by a single cell sort recognized by microarray and next-generation sequencing. RNA Biol. 2017;14:58–72.
Rahbarghazi R, Jabbari N, Sani NA, Asghari R, Salimi L, Kalashani SA, Feghhi M, Etemadi T, Akbariazar E, Mahmoudi M, Rezaie J. Tumor-derived extracellular vesicles: dependable instruments for Most cancers analysis and medical functions. Cell Commun Sign. 2019;17:73.
Konečná B, Tóthová Ľ, Repiská G. Exosomes-Related DNA-New Marker in Being pregnant Issues? Int J Mol Sci. 2019;20:2890.
O’Brien Okay, Breyne Okay, Ughetto S, Laurent LC, Breakefield XO. RNA supply by extracellular vesicles in mammalian cells and its functions. Nat Rev Mol Cell Biol. 2020;21:585–606.
Terstappen GC, Meyer AH, Bell RD, Zhang W. Methods for delivering therapeutics throughout the blood-brain barrier. Nat Rev Drug Discov. 2021;20:362–83.
Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG. Therapeutic properties of mesenchymal stromal/stem cells: the necessity of cell priming for cell-free therapies in regenerative drugs. Int J Mol Sci. 2021;22:234.
Mendt M, Rezvani Okay, Shpall E. Mesenchymal stem cell-derived exosomes for medical use. Bone Marrow Transplant. 2019;54:789–92.
Xunian Z, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes. Most cancers Sci. 2020;111:3100–10.
Pomatto M, Gai C, Negro F, Cedrino M, Grange C, Ceccotti E, Togliatto G, Collino F, Tapparo M, Figliolini F, et al. Differential therapeutic impact of extracellular vesicles derived by bone marrow and adipose mesenchymal stem cells on wound therapeutic of diabetic ulcers and correlation to their cargoes. Int J Mol Sci. 2021;22:23.
Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells enhance hepatocellular carcinoma chemosensitivity via mTOR pathway. J Exp Clin Most cancers Res. 2020;39:4.
Li T, Zhou X, Wang J, Liu Z, Han S, Wan L, Solar X, Chen H. Adipose-derived mesenchymal stem cells and extracellular vesicles confer antitumor exercise in preclinical therapy of breast most cancers. Pharmacol Res. 2020;157:104843.
Wang S, Solar J, Dastgheyb RM, Li Z. Tumor-derived extracellular vesicles modulate innate immune responses to have an effect on tumor development. Entrance Immunol. 2022;13:1045624.
Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. The advanced position of tumor-infiltrating macrophages. Nat Immunol. 2022;23:1148–56.
Wu Okay, Lin Okay, Li X, Yuan X, Xu P, Ni P, Xu D. Redefining tumor-associated macrophage subpopulations and capabilities within the tumor microenvironment. Entrance Immunol. 2020;11:1731.
Nie W, Wu G, Zhang J, Huang LL, Ding J, Jiang A, Zhang Y, Liu Y, Li J, Pu Okay, Xie HY. Responsive exosome nano-bioconjugates for synergistic most cancers remedy. Angew Chem Int Ed Engl. 2020;59:2018–22.
Marar C, Starich B, Wirtz D. Extracellular vesicles in immunomodulation and tumor development. Nat Immunol. 2021;22:560–70.
Lindenbergh MFS, Stoorvogel W. Antigen presentation by extracellular vesicles from skilled antigen-presenting cells. Annu Rev Immunol. 2018;36:435–59.
Xu Z, Zeng S, Gong Z, Yan Y. Exosome-based immunotherapy: a promising method for most cancers therapy. Mol Most cancers. 2020;19:160.
Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z, Qi H, Guo H, Yin H. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse fashions. J Hepatol. 2017;67:739–48.
Vergani E, Daveri E, Vallacchi V, Bergamaschi L, Lalli L, Castelli C, Rodolfo M, Rivoltini L, Huber V. Extracellular vesicles in anti-tumor immunity. Semin Most cancers Biol. 2022;86:64–79.
Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, et al. Tumor-derived exosomes are a supply of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7:297–303.
Rana S, Yue S, Stadel D, Zöller M. Towards tailor-made exosomes: the exosomal tetraspanin internet contributes to focus on cell choice. Int J Biochem Cell Biol. 2012;44:1574–84.
Fang JH, Zhang ZJ, Shang LR, Luo YW, Lin YF, Yuan Y, Zhuang SM. Hepatoma cell-secreted exosomal microRNA-103 will increase vascular permeability and promotes metastasis by concentrating on junction proteins. Hepatology. 2018;68:1459–75.
Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Section I medical trial of autologous ascites-derived exosomes mixed with GM-CSF for colorectal most cancers. Mol Ther. 2008;16:782–90.
Liu C, Su C. Design methods and software progress of therapeutic exosomes. Theranostics. 2019;9:1015–28.
Mu J, Zhuang X, Wang Q, Jiang H, Deng ZB, Wang B, Zhang L, Kakar S, Jun Y, Miller D, Zhang HG. Interspecies communication between plant and mouse intestine host cells via edible plant derived exosome-like nanoparticles. Mol Nutr Meals Res. 2014;58:1561–73.
Cai Q, Qiao L, Wang M, He B, Lin FM, Palmquist J, Huang SD, Jin H. Crops ship small RNAs in extracellular vesicles to fungal pathogen to silence virulence genes. Science. 2018;360:1126–9.
Tinnirello V, Rabienezhad Ganji N, De Marcos LC, Alessandro R, Raimondo S. Exploiting the chance to make use of plant-derived nanoparticles as supply autos. Crops (Basel). 2023;12:1207.
Dong F, Dong X, Zhou L, Xiao H, Ho PY, Wong MS, Wang Y. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer impact: Preparation, in vitro analysis, and mobile uptake. Colloids Surf B Biointerfaces. 2016;140:324–31.
Del Pozo-Acebo L. Therapeutic potential of broccoli-derived extracellular vesicles as nanocarriers of exogenous miRNAs. Pharmacol Res. 2022;185: 106472.
Zhuang X, Deng ZB, Mu J, Zhang L, Yan J, Miller D, Feng W, McClain CJ, Zhang HG. Ginger-derived nanoparticles shield in opposition to alcohol-induced liver harm. J Extracell Vesicles. 2015;4:28713.
Rahimi Ghiasi M, Rahimi E, Amirkhani Z, Salehi R. Leucine-rich Repeat-containing G-protein coupled receptor 5 gene overexpression of the rat small intestinal progenitor cells in response to orally administered grape exosome-like nanovesicles. Adv Biomed Res. 2018;7:125.
Liangsupree T, Multia E, Riekkola ML. Trendy isolation and separation methods for extracellular vesicles. J Chromatogr A. 2021;1636: 461773.
Wang C, Xu M, Fan Q, Li C, Zhou X. Therapeutic potential of exosome-based personalised supply platform in power inflammatory ailments. Asian J Pharm Sci. 2023;18:100772.
Franco C, Ghirardello A, Bertazza L, Gasparotto M, Zanatta E, Iaccarino L, Valadi H, Doria A, Gatto M. Measurement-exclusion chromatography mixed with ultrafiltration effectively isolates extracellular vesicles from human blood samples in well being and illness. Int J Mol Sci. 2023;24:34.
Jeppesen DK, Hvam ML, Primdahl-Bengtson B, Boysen AT, Whitehead B, Dyrskjøt L, Orntoft TF, Howard KA, Ostenfeld MS. Comparative evaluation of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles. 2014;3:25011.
Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, Larcher LM, Chen S, Liu N, Zhao Q, et al. Progress, alternative, and perspective on exosome isolation – efforts for environment friendly exosome-based theranostics. Theranostics. 2020;10:3684–707.
Tran PHL, Wang T, Yin W, Tran TTD, Nguyen TNG, Lee BJ, Duan W. Aspirin-loaded nanoexosomes as most cancers therapeutics. Int J Pharm. 2019;572: 118786.
Paolini L, Zendrini A, Di Noto G, Busatto S, Lottini E, Radeghieri A, Dossi A, Caneschi A, Ricotta D, Bergese P. Residual matrix from totally different separation methods impacts exosome organic exercise. Sci Rep. 2016;6:23550.
Liu J, Chen Y, Pei F, Zeng C, Yao Y, Liao W, Zhao Z. Extracellular vesicles in liquid biopsies: potential for illness analysis. Biomed Res Int. 2021;2021:6611244.
Yang J, Gao X, Xing X, Huang H, Tang Q, Ma S, Xu X, Liang C, Li M, Liao L, Tian W. An isolation system to gather top quality and purity extracellular vesicles from serum. Int J Nanomedicine. 2021;16:6681–92.
Bordas M, Genard G, Ohl S, Nessling M, Richter Okay, Roider T, Dietrich S, Maaß KK, Seiffert M. Optimized protocol for isolation of small extracellular vesicles from human and murine lymphoid tissues. Int J Mol Sci. 2020;21:78.
Tulkens J, De Wever O, Hendrix A. Analyzing bacterial extracellular vesicles in human physique fluids by orthogonal biophysical separation and biochemical characterization. Nat Protoc. 2020;15:40–67.
Ilahibaks NF, Lei Z, Mol EA, Deshantri AK, Jiang L, Schiffelers RM, Vader P, Sluijter JPG. Biofabrication of cell-derived nanovesicles: a possible different to extracellular vesicles for regenerative drugs. Cells. 2019;8:34.
Shirejini SZ, Inci F. The Yin and Yang of exosome isolation strategies: typical follow, microfluidics, and business kits. Biotechnol Adv. 2022;54: 107814.
Patel GK, Khan MA, Zubair H, Srivastava SK, Khushman M, Singh S, Singh AP. Comparative evaluation of exosome isolation strategies utilizing tradition supernatant for optimum yield, purity and downstream functions. Sci Rep. 2019;9:5335.
Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation methods. Theranostics. 2017;7:789–804.
Sidhom Okay, Obi PO, Saleem A. A evaluate of exosomal isolation strategies: is dimension exclusion chromatography the best choice? Int J Mol Sci. 2020;21:34.
Vergauwen G, Dhondt B, Van Deun J, De Smedt E, Berx G, Timmerman E, Gevaert Okay, Miinalainen I, Cocquyt V, Braems G, et al. Confounding components of ultrafiltration and protein evaluation in extracellular vesicle analysis. Sci Rep. 2017;7:2704.
He L, Zhu D, Wang J, Wu X. A extremely environment friendly methodology for isolating urinary exosomes. Int J Mol Med. 2019;43:83–90.
Kim JY, Rhim WK, Yoo YI, Kim DS, Ko KW, Heo Y, Park CG, Han DK. Outlined MSC exosome with excessive yield and purity to enhance regenerative exercise. J Tissue Eng. 2021;12:20417314211008624.
Li A, Zhang T, Zheng M, Liu Y, Chen Z. Exosomal proteins as potential markers of tumor analysis. J Hematol Oncol. 2017;10:175.
Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Show of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell concentrating on. J Extracell Vesicles. 2016;5:31053.
Zarovni N, Corrado A, Guazzi P, Zocco D, Lari E, Radano G, Muhhina J, Fondelli C, Gavrilova J, Chiesi A. Built-in isolation and quantitative evaluation of exosome shuttled proteins and nucleic acids utilizing immunocapture approaches. Strategies. 2015;87:46–58.
Pallares-Rusiñol A, Moura SL, Martí M, Pividori MI. Electrochemical genosensing of overexpressed GAPDH transcripts in breast most cancers exosomes. Anal Chem. 2023;95:2487–95.
Liu WZ, Ma ZJ, Kang XW. Present standing and outlook of advances in exosome isolation. Anal Bioanal Chem. 2022;414:7123–41.
Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: common methodologies and newest traits. Biomed Res Int. 2018;2018:8545347.
Choi DY, Park JN, Paek SH, Choi SC, Paek SH. Detecting early-stage malignant melanoma utilizing a calcium switch-enriched exosome subpopulation containing tumor markers as a pattern. Biosens Bioelectron. 2022;198: 113828.
Biagiotti S, Abbas F, Montanari M, Barattini C, Rossi L, Magnani M, Papa S, Canonico B. Extracellular vesicles as new gamers in drug supply: a give attention to pink blood cells-derived EVs. Pharmaceutics. 2023;15:34.
Ryu KJ, Lee JY, Park C, Cho D, Kim SJ. Isolation of small extracellular vesicles from human serum utilizing a mix of ultracentrifugation with polymer-based precipitation. Ann Lab Med. 2020;40:253–8.
Gallart-Palau X, Serra A, Sze SK. Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR. Mol Neurodegener. 2016;11:41.
Yasui T, Paisrisarn P, Yanagida T, Konakade Y, Nakamura Y, Nagashima Okay, Musa M, Thiodorus IA, Takahashi H, Naganawa T, et al. Molecular profiling of extracellular vesicles through charge-based seize utilizing oxide nanowire microfluidics. Biosens Bioelectron. 2021;194: 113589.
Lin B, Lei Y, Wang J, Zhu L, Wu Y, Zhang H, Wu L, Zhang P, Yang C. Microfluidic-based exosome evaluation for liquid biopsy. Small Strategies. 2021;5: e2001131.
Yang Q, Cheng L, Hu L, Lou D, Zhang T, Li J, Zhu Q, Liu F. An integrative microfluidic gadget for isolation and ultrasensitive detection of lung cancer-specific exosomes from affected person urine. Biosens Bioelectron. 2020;163: 112290.
Lo TW, Zhu Z, Purcell E, Watza D, Wang J, Kang YT, Jolly S, Nagrath D, Nagrath S. Microfluidic gadget for high-throughput affinity-based isolation of extracellular vesicles. Lab Chip. 2020;20:1762–70.
Yang J, Pan B, Zeng F, He B, Gao Y, Liu X, Tune Y. Magnetic colloid antibodies speed up small extracellular vesicles isolation for point-of-care diagnostics. Nano Lett. 2021;21:2001–9.
Chen H, Yamakawa T, Inaba M, Nakano M, Suehiro J. Characterization of extra-cellular vesicle dielectrophoresis and estimation of its electrical properties. Sensors (Basel). 2022;22:34.
Broman A, Lenshof A, Evander M, Happonen L, Ku A, Malmström J, Laurell T. Multinodal acoustic trapping permits excessive capability and excessive throughput enrichment of extracellular vesicles and microparticles in miRNA and MS proteomics research. Anal Chem. 2021;93:3929–37.
Culbertson CT, Mickleburgh TG, Stewart-James SA, Sellens KA, Pressnall M. Micro whole evaluation programs: basic advances and organic functions. Anal Chem. 2014;86:95–118.
Wang C, Zhang D, Yang H, Shi L, Li L, Yu C, Wei J, Ding Q. A light-weight-activated magnetic bead technique utilized in spatio-temporal controllable exosomes isolation. Entrance Bioeng Biotechnol. 2022;10:1006374.
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, et al. Minimal info for research of extracellular vesicles 2018 (MISEV2018): a place assertion of the Worldwide Society for Extracellular Vesicles and replace of the MISEV2014 tips. J Extracell Vesicles. 2018;7:1535750.
Yu Y, Li YT, Jin D, Yang F, Wu D, Xiao MM, Zhang H, Zhang ZY, Zhang GJ. Electrical and label-free quantification of exosomes with a diminished graphene oxide subject impact transistor biosensor. Anal Chem. 2019;91:10679–86.
Cosenza S, Ruiz M, Toupet Okay, Jorgensen C, Noël D. Mesenchymal stem cells derived exosomes and microparticles shield cartilage and bone from degradation in osteoarthritis. Sci Rep. 2017;7:16214.
Wu JY, Li YJ, Hu XB, Huang S, Xiang DX. Preservation of small extracellular vesicles for useful evaluation and therapeutic functions: a comparative analysis of storage situations. Drug Deliv. 2021;28:162–70.
Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a evaluate of its classification, isolation methods, storage, diagnostic and focused remedy functions. Int J Nanomedicine. 2020;15:6917–34.
Charoenviriyakul C, Takahashi Y, Nishikawa M, Takakura Y. Preservation of exosomes at room temperature utilizing lyophilization. Int J Pharm. 2018;553:1–7.
Kusuma GD, Barabadi M, Tan JL, Morton DAV, Frith JE, Lim R. To guard and to protect: novel preservation methods for extracellular vesicles. Entrance Pharmacol. 2018;9:1199.
Xu M, Yang Q, Solar X, Wang Y. Latest developments within the loading and modification of therapeutic exosomes. Entrance Bioeng Biotechnol. 2020;8: 586130.
Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Viganò L, Locatelli A, Sisto F, Doglia SM, et al. Paclitaxel is included by mesenchymal stromal cells and launched in exosomes that inhibit in vitro tumor development: a brand new method for drug supply. J Management Launch. 2014;192:262–70.
Bonomi A, Sordi V, Dugnani E, Ceserani V, Dossena M, Coccè V, Cavicchini L, Ciusani E, Bondiolotti G, Piovani G, et al. Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells. Cytotherapy. 2015;17:1687–95.
Toffoli G, Hadla M, Corona G, Caligiuri I, Palazzolo S, Semeraro S, Gamini A, Canzonieri V, Rizzolio F. Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin. Nanomedicine (Lond). 2015;10:2963–71.
Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, et al. Technology and testing of clinical-grade exosomes for pancreatic most cancers. JCI Perception. 2018;3:78.
Haney MJ, Zhao Y, Jin YS, Li SM, Bago JR, Klyachko NL, Kabanov AV, Batrakova EV. Macrophage-derived extracellular vesicles as drug supply programs for triple damaging breast most cancers (TNBC) Remedy. J Neuroimmune Pharmacol. 2020;15:487–500.
Sancho-Albero M, Encabo-Berzosa MDM, Beltrán-Visiedo M, Fernández-Messina L, Sebastián V, Sánchez-Madrid F, Arruebo M, Santamaría J, Martín-Duque P. Environment friendly encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to acquire hole gold nanoparticle-hybrids. Nanoscale. 2019;11:18825–36.
Solar H, Zhang T, Gao J. Extracellular vesicles derived from mesenchymal stem cells: a possible biodrug for acute respiratory misery syndrome therapy. BioDrugs. 2022;36:701–15.
Ma X, Liu B, Fan L, Liu Y, Zhao Y, Ren T, Li Y, Li Y. Native and engineered exosomes for inflammatory illness. Nano Res. 2023;16:6991–7006.
Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, Kabanov AV, Batrakova EV. Engineering macrophage-derived exosomes for focused paclitaxel supply to pulmonary metastases: in vitro and in vivo evaluations. Nanomedicine. 2018;14:195–204.
Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si Okay, Solar B, Chen B, Xiao Z. Engineered exosomes for focused co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon most cancers. J Nanobiotechnology. 2020;18:10.
Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and supply effectivity of unmodified tumor-derived exosomes. J Management Launch. 2015;199:145–55.
Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Useful extracellular vesicles for regenerative drugs. Small. 2022;18: e2106569.
Choi H, Choi Y, Yim HY, Mirzaaghasi A, Yoo JK, Choi C. Biodistribution of exosomes and engineering methods for focused supply of therapeutic exosomes. Tissue Eng Regen Med. 2021;18:499–511.
Salunkhe S. Floor functionalization of exosomes for target-specific supply and in vivo imaging & monitoring: Methods and significance. J Management Launch. 2020;326:599–614.
Longatti A, Schindler C, Collinson A, Jenkinson L, Matthews C, Fitzpatrick L, Blundy M, Minter R, Vaughan T, Shaw M, Tigue N. Excessive affinity single-chain variable fragments are particular and versatile concentrating on motifs for extracellular vesicles. Nanoscale. 2018;10:14230–44.
Wang C, Li N, Li Y, Hou S, Zhang W, Meng Z, Wang S, Jia Q, Tan J, Wang R, Zhang R. Engineering a HEK-293T exosome-based supply platform for environment friendly tumor-targeting chemotherapy/inner irradiation mixture remedy. J Nanobiotechnology. 2022;20:247.
Yoon HY, Lee D, Lim DK, Koo H, Kim Okay. Copper-free click on chemistry: functions in drug supply, cell monitoring, and tissue engineering. Adv Mater. 2022;34: e2107192.
Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, Huang NP, Xiao ZD, Lu ZH, Tannous BA, Gao J. Floor functionalized exosomes as focused drug supply autos for cerebral ischemia remedy. Biomaterials. 2018;150:137–49.
Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, Kim IS. Exosome-SIRPα, a CD47 blockade will increase most cancers cell phagocytosis. Biomaterials. 2017;121:121–9.
Takayama Y, Kusamori Okay, Nishikawa M. Click on Chemistry as a Software for Cell Engineering and Drug Supply. Molecules. 2019;24:8.
Hong Y, Nam SM, Moon A. Antibody-drug conjugates and bispecific antibodies concentrating on cancers: functions of click on chemistry. Arch Pharm Res. 2023;46:131–48.
Qi H, Liu C, Lengthy L, Ren Y, Zhang S, Chang X, Qian X, Jia H, Zhao J, Solar J, et al. Blood exosomes endowed with magnetic and concentrating on properties for most cancers remedy. ACS Nano. 2016;10:3323–33.
Lv Y, Du X, Tang W, Yang Q, Gao F. Exosomes: the position in tumor tolerance and the potential technique for tumor remedy. Pharmaceutics. 2023;15:462.
Kooijmans SAA, Fliervoet LAL, van der Meel R, Fens M, Heijnen HFG. PEGylated and focused extracellular vesicles show enhanced cell specificity and circulation time. J Management Launch. 2016;224:77–85.
Gao X, Ran N, Dong X, Zuo B, Yang R, Zhou Q, Moulton HM, Seow Y, Yin H. Anchor peptide captures, targets, and hundreds exosomes of numerous origins for diagnostics and remedy. Sci Transl Med. 2018;10:444.
Donoso-Quezada J, Ayala-Mar S, González-Valdez J. State-of-the-art exosome loading and functionalization methods for enhanced therapeutics: a evaluate. Crit Rev Biotechnol. 2020;40:804–20.
Rayamajhi S, Nguyen TDT, Marasini R, Aryal S. Macrophage-derived exosome-mimetic hybrid vesicles for tumor focused drug supply. Acta Biomater. 2019;94:482–94.
Sato YT, Umezaki Okay, Sawada S, Mukai SA, Sasaki Y, Harada N, Shiku H, Akiyoshi Okay. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6:21933.
Lee J, Lee H, Goh U, Kim J, Jeong M, Lee J, Park JH. Mobile engineering with membrane fusogenic liposomes to provide functionalized extracellular vesicles. ACS Appl Mater Interfaces. 2016;8:6790–5.
Lv Q, Cheng L, Lu Y, Zhang X, Wang Y, Deng J, Zhou J, Liu B, Liu J. Thermosensitive exosome-liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved therapy of metastatic peritoneal most cancers. Adv Sci (Weinh). 2020;7:2000515.
Lin Y, Wu J, Gu W, Huang Y, Tong Z, Huang L, Tan J. Exosome-liposome hybrid nanoparticles ship CRISPR/Cas9 System in MSCs. Adv Sci (Weinh). 2018;5:1700611.
O’Brien Okay, Ughetto S, Mahjoum S, Nair AV, Breakefield XO. Uptake, performance, and re-release of extracellular vesicle-encapsulated cargo. Cell Rep. 2022;39: 110651.
Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:78.
Sinha D, Roy S, Saha P, Chatterjee N, Bishayee A. Traits in analysis on exosomes in most cancers development and anticancer remedy. Cancers (Basel). 2021;13:8.
Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y. Visualization and in vivo monitoring of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013;165:77–84.
Yin Y, Han X, Li C, Solar T, Li Okay, Liu X, Liu M. The standing of industrialization and growth of exosomes as a drug supply system: A evaluate. Entrance Pharmacol. 2022;13: 961127.
Miyanishi M, Tada Okay, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007;450:435–9.
Wang D, Wan Z, Yang Q, Chen J, Liu Y, Lu F, Tang J. Sonodynamical reversion of immunosuppressive microenvironment in prostate most cancers through engineered exosomes. Drug Deliv. 2022;29:702–13.
Das CK, Jena BC, Banerjee I, Das S, Parekh A, Bhutia SK, Mandal M. Exosome as a novel shuttle for supply of therapeutics throughout organic boundaries. Mol Pharm. 2019;16:24–40.
Tolomeo AM, Zuccolotto G, Malvicini R, De Lazzari G, Penna A, Franco C, Caicci F, Magarotto F, Quarta S, Pozzobon M, et al. Biodistribution of intratracheal, intranasal, and intravenous injections of human mesenchymal stromal cell-derived extracellular vesicles in a mouse mannequin for drug supply research. Pharmaceutics. 2023;15:548.
Perets N, Betzer O, Shapira R, Brenstein S, Angel A, Sadan T, Ashery U, Popovtzer R, Offen D. Golden exosomes selectively goal mind pathologies in neurodegenerative and neurodevelopmental problems. Nano Lett. 2019;19:3422–31.
Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia Okay, Tekade RK. Employment of enhanced permeability and retention impact (EPR): Nanoparticle-based precision instruments for concentrating on of therapeutic and diagnostic agent in most cancers. Mater Sci Eng C Mater Biol Appl. 2019;98:1252–76.
Nam GH, Choi Y, Kim GB, Kim S, Kim SA, Kim IS. Rising prospects of exosomes for most cancers therapy: from typical remedy to immunotherapy. Adv Mater. 2020;32: e2002440.
Gong C, Zhang X, Shi M, Li F, Wang S, Wang Y, Wang Y, Wei W, Ma G. Tumor exosomes reprogrammed by low pH are environment friendly concentrating on autos for sensible drug supply and personalised remedy in opposition to their homologous tumor. Adv Sci (Weinh). 2021;8:2002787.
Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F, Hakeem A, Hu J, Gan L, Santos HA, Yang X. Tumor exosome-based nanoparticles are environment friendly drug carriers for chemotherapy. Nat Commun. 2019;10:3838.
Yong T, Wang D, Li X, Yan Y, Hu J, Gan L, Yang X. Extracellular vesicles for tumor concentrating on supply based mostly on 5 options precept. J Management Launch. 2020;322:555–65.
Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O, et al. Improvement of exosome-encapsulated paclitaxel to beat MDR in most cancers cells. Nanomedicine. 2016;12:655–64.
Wei H, Chen J, Wang S, Fu F, Zhu X, Wu C, Liu Z, Zhong G, Lin J. A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma therapy in vitro. Int J Nanomedicine. 2019;14:8603–10.
Wei H, Chen F, Chen J, Lin H, Wang S, Wang Y, Wu C, Lin J, Zhong G. Mesenchymal stem cell derived exosomes as nanodrug service of doxorubicin for focused osteosarcoma remedy through SDF1-CXCR4 Axis. Int J Nanomedicine. 2022;17:3483–95.
Bukowski Okay, Kciuk M, Kontek R. Mechanisms of multidrug resistance in most cancers chemotherapy. Int J Mol Sci. 2020;21:34.
Walczak H, Miller RE, Ariail Okay, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, et al. Tumoricidal exercise of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5:157–63.
van der Sloot AM, Tur V, Szegezdi E, Mullally MM, Cool RH, Samali A, Serrano L, Quax WJ. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis solely through the DR5 receptor. Proc Natl Acad Sci U S A. 2006;103:8634–9.
Dianat-Moghadam H, Heidarifard M, Mahari A, Shahgolzari M, Keshavarz M, Nouri M, Amoozgar Z. TRAIL in oncology: from recombinant TRAIL to nano- and self-targeted TRAIL-based therapies. Pharmacol Res. 2020;155: 104716.
Jiang L, Gu Y, Du Y, Tang X, Wu X, Liu J. Engineering exosomes endowed with focused supply of triptolide for malignant melanoma remedy. ACS Appl Mater Interfaces. 2021;13:42411–28.
Qiu Y, Solar J, Qiu J, Chen G, Wang X, Mu Y, Li Okay, Wang W. Antitumor Exercise of Cabazitaxel and MSC-TRAIL derived extracellular vesicles in drug-resistant oral squamous cell carcinoma. Most cancers Manag Res. 2020;12:10809–20.
Yuan Q, Su Okay, Li S, Lengthy X, Liu L, Yang M, Yuan X, Solar J, Hu J, Li Q, et al. Pulmonary supply of extracellular vesicle-encapsulated dinaciclib as an efficient lung most cancers remedy. Cancers (Basel). 2022;14:89.
Gu Y, Du Y, Jiang L, Tang X, Li A, Zhao Y, Lang Y, Liu X, Liu J. αvβ3 integrin-specific exosomes engineered with cyclopeptide for focused supply of triptolide in opposition to malignant melanoma. J Nanobiotechnology. 2022;20:384.
Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding X, Qiang L, Li G, Han Z, Yuan Y, Gao S. Useful exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast most cancers remedy. J Nanobiotechnology. 2019;17:93.
Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel goal for most cancers therapeutics. Clin Most cancers Res. 2008;14:5000–5.
Zhang X, Males Okay, Zhang Y, Zhang R, Yang L, Duan X. Native and systemic supply of mRNA encoding survivin-T34A by lipoplex for environment friendly colon most cancers gene remedy. Int J Nanomedicine. 2019;14:2733–51.
Aspe JR, Diaz Osterman CJ, Jutzy JM, Deshields S, Whang S, Wall NR. Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated supply of the Survivin-T34A mutant. J Extracell Vesicles. 2014;3:23.
Yim N, Ryu SW, Choi Okay, Lee KR, Lee S, Choi H, Kim J, Shaker MR, Solar W, Park JH, et al. Exosome engineering for environment friendly intracellular supply of soluble proteins utilizing optically reversible protein-protein interplay module. Nat Commun. 2016;7:12277.
Nordmeier S, Ke W, Afonin KA, Portnoy V. Exosome mediated supply of useful nucleic acid nanoparticles (NANPs). Nanomedicine. 2020;30: 102285.
Zhang Y, Liu Q, Zhang X, Huang H, Tang S, Chai Y, Xu Z, Li M, Chen X, Liu J, Yang C. Latest advances in exosome-mediated nucleic acid supply for most cancers remedy. J Nanobiotechnology. 2022;20:279.
Kamerkar S, Burzyn D, Leng C, Burenkova O, Jang SC, Yang R, Boutin A, Kirwin Okay, Zi T, Dahlberg W, et al. Summary A50: Reprogramming of tumor-associated M2 macrophages with antisense oligonucleotide-loaded exosomes leads to potent single-agent antitumor exercise. Most cancers Immunol Res. 2020;8:A50–A50.
Wilbie D, Walther J, Mastrobattista E. Supply features of CRISPR/Cas for in vivo genome modifying. Acc Chem Res. 2019;52:1555–64.
McAndrews KM, Xiao F, Chronopoulos A, LeBleu VS, Kugeratski FG, Kalluri R. Exosome-mediated supply of CRISPR/Cas9 for concentrating on of oncogenic Kras(G12D) in pancreatic most cancers. Life Sci Alliance. 2021;4:875.
Wang JK, Wang Z, Li G. MicroRNA-125 in immunity and most cancers. Most cancers Lett. 2019;454:134–45.
Wang X, Zhang H, Bai M, Ning T, Ge S, Deng T, Liu R, Zhang L, Ying G, Ba Y. Exosomes function nanoparticles to ship anti-miR-214 to reverse chemoresistance to cisplatin in gastric most cancers. Mol Ther. 2018;26:774–83.
Yan Y, Du C, Duan X, Yao X, Wan J, Jiang Z, Qin Z, Li W, Pan L, Gu Z, et al. Inhibiting collagen I manufacturing and tumor cell colonization within the lung through miR-29a-3p loading of exosome-/liposome-based nanovesicles. Acta Pharm Sin B. 2022;12:939–51.
Kirave P, Gondaliya P, Kulkarni B, Rawal R, Garg R, Jain A, Kalia Okay. Exosome mediated miR-155 supply confers cisplatin chemoresistance in oral most cancers cells through epithelial-mesenchymal transition. Oncotarget. 2020;11:1157–71.
Castanotto D, Rossi JJ. The guarantees and pitfalls of RNA-interference-based therapeutics. Nature. 2009;457:426–33.
Tatiparti Okay, Sau S, Kashaw SK, Iyer AK. siRNA Supply Methods: A Complete Evaluation of Latest Developments. Nanomaterials (Basel). 2017;7:89.
Lin D, Zhang H, Liu R, Deng T, Ning T, Bai M, Yang Y, Zhu Okay, Wang J, Duan J, et al. iRGD-modified exosomes successfully ship CPT1A siRNA to colon most cancers cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Mol Oncol. 2021;15:3430–46.
Xia J, Miao Y, Wang X, Huang X, Dai J. Latest progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine. Biomed Pharmacother. 2022;152: 113250.
Kugeratski FG, Kalluri R. Exosomes as mediators of immune regulation and immunotherapy in most cancers. Febs j. 2021;288:10–35.
Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W. Organic drug and drug delivery-mediated immunotherapy. Acta Pharm Sin B. 2021;11:941–60.
Zhang H, Wang S, Solar M, Cui Y, Xing J, Teng L, Xi Z, Yang Z. Exosomes as sensible drug supply autos for most cancers immunotherapy. Entrance Immunol. 2022;13:1093607.
Fu C, Zhou L, Mi QS, Jiang A. Plasmacytoid dendritic cells and most cancers immunotherapy. Cells. 2022;11:67.
Wang R, Xu A, Zhang X, Wu J, Freywald A, Xu J, Xiang J. Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in power an infection through CD40L signaling via the mTORC1 pathway. Cell Mol Immunol. 2017;14:529–45.
Lee EY, Park KS, Yoon YJ, Lee J, Moon HG, Jang SC, Choi KH, Kim YK, Gho YS. Therapeutic results of autologous tumor-derived nanovesicles on melanoma development and metastasis. PLoS ONE. 2012;7:e33330.
Fu C, Zhou L, Mi QS, Jiang A. DC-Based mostly Vaccines for Most cancers Immunotherapy. Vaccines (Basel). 2020;8:78.
Stefanius Okay, Servage Okay, de Souza SM, Grey HF, Toombs JE, Chimalapati S, Kim MS, Malladi VS, Brekken R, Orth Okay. Human pancreatic most cancers cell exosomes, however not human regular cell exosomes, act as an initiator in cell transformation. Elife. 2019;8:345.
Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, et al. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy operate in opposition to complement-mediated cytotoxicity. Nat Commun. 2019;10:254.
Pagotto S, Simeone P, Brocco D, Catitti G, De Bellis D, Vespa S, Di Pietro N, Marinelli L, Di Stefano A, Veschi S, et al. CAR-T-derived extracellular vesicles: a promising growth of CAR-T anti-tumor remedy. Cancers (Basel). 2023;15:4.
Schubert ML, Schmitt M, Wang L, Ramos CA, Jordan Okay, Müller-Tidow C, Dreger P. Aspect-effect administration of chimeric antigen receptor (CAR) T-cell remedy. Ann Oncol. 2021;32:34–48.
Hernani R, Benzaquén A, Solano C. Toxicities following CAR-T remedy for hematological malignancies. Most cancers Deal with Rev. 2022;111: 102479.
Fu W, Lei C, Liu S, Cui Y, Wang C, Qian Okay, Li T, Shen Y, Fan X, Lin F, et al. CAR exosomes derived from effector CAR-T cells have potent antitumour results and low toxicity. Nat Commun. 2019;10:4355.
Shi Y, Zhang J, Mao Z, Jiang H, Liu W, Shi H, Ji R, Xu W, Qian H, Zhang X. Extracellular vesicles from gastric most cancers cells induce PD-L1 expression on neutrophils to suppress T-cell immunity. Entrance Oncol. 2020;10:629.
Zocchi MR, Tosetti F, Benelli R, Poggi A. Most cancers Nanomedicine Particular Concern Evaluation Anticancer Drug Supply with Nanoparticles: Extracellular Vesicles or Artificial Nanobeads as Therapeutic Instruments for Typical Remedy or Immunotherapy. Cancers Basel 2020; 12:34
Fan Y, Zhou Y, Lu M, Si H, Li L, Tang B. Responsive dual-targeting exosome as a drug service for mixture most cancers immunotherapy. Analysis (Wash D C). 2021;2021:9862876.
Wang D, Wang C, Wang L, Chen Y. A complete evaluate in bettering supply of small-molecule chemotherapeutic brokers overcoming the blood-brain/mind tumor boundaries for glioblastoma therapy. Drug Deliv. 2019;26:551–65.
Conti A, Geffroy F, Kamimura HAS, Novell A, Tournier N, Mériaux S, Larrat B. Regulation of P-glycoprotein and breast most cancers resistance protein expression induced by targeted ultrasound-mediated blood-brain barrier disruption: a pilot examine. Int J Mol Sci. 2022;23:34.
van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. Overcoming the blood-brain tumor barrier for efficient glioblastoma therapy. Drug Resist Updat. 2015;19:1–12.
Xu M, Feng T, Liu B, Qiu F, Xu Y, Zhao Y, Zheng Y. Engineered exosomes: fascinating target-tracking traits for cerebrovascular and neurodegenerative illness therapies. Theranostics. 2021;11:8926–44.
Deng Z, Wang J, Xiao Y, Li F, Niu L, Liu X, Meng L, Zheng H. Ultrasound-mediated augmented exosome launch from astrocytes alleviates amyloid-β-induced neurotoxicity. Theranostics. 2021;11:4351–62.
Yang T, Martin P, Fogarty B, Brown A, Schurman Okay, Phipps R, Yin VP, Lockman P, Bai S. Exosome delivered anticancer medication throughout the blood-brain barrier for mind most cancers remedy in Danio rerio. Pharm Res. 2015;32:2003–14.
Yang T, Fogarty B, LaForge B, Aziz S, Pham T, Lai L, Bai S. Supply of small interfering RNA to inhibit vascular endothelial development consider zebrafish utilizing pure mind endothelia cell-secreted exosome nanovesicles for the therapy of mind most cancers. Aaps j. 2017;19:475–86.
Liang SF, Zuo FF, Yin BC, Ye BC. Supply of siRNA based mostly on engineered exosomes for glioblastoma remedy by concentrating on STAT3. Biomater Sci. 2022;10:1582–90.
Reale A, Khong T, Spencer A. Extracellular vesicles and their roles within the tumor immune microenvironment. J Clin Med. 2022;11:23.
Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as instruments and targets in most cancers remedy. Nat Rev Drug Discov. 2022;21:799–820.
Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017;79:541–66.
Kamerkar S, Leng C, Burenkova O, Jang SC, McCoy C, Zhang Okay, Dooley Okay, Kasera S, Zi T, Sisó S, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 results in potent monotherapy antitumor exercise. Sci Adv. 2022;8:eabj7002.
Zhu D, Liu Z, Li Y, Huang Q, Xia L, Li Okay. Supply of manganese carbonyl to the tumor microenvironment utilizing Tumor-Derived exosomes for most cancers gasoline remedy and low dose radiotherapy. Biomaterials. 2021;274: 120894.
Zhang M, Hu S, Liu L, Dang P, Liu Y, Solar Z, Qiao B, Wang C. Engineered exosomes from totally different sources for cancer-targeted remedy. Sign Transduct Goal Ther. 2023;8:124.
Gomes ER, Carvalho AT, Barbosa TC, Ferreira LL, Calado HDR, Sabino AP, Oliveira MC. Fusion of tumor-derived exosomes with long-circulating and pH-sensitive liposomes loaded with doxorubicin for the therapy of breast most cancers. AAPS PharmSciTech. 2022;23:255.
Gomes ER, Souza FR, Cassali GD, Sabino AP, Barros ALB, Oliveira MC. Investigation of the antitumor exercise and toxicity of tumor-derived exosomes fused with long-circulating and pH-sensitive liposomes containing doxorubicin. Pharmaceutics. 2022;14:3.
Alix-Panabières C, Pantel Okay. Liquid biopsy: from discovery to medical software. Most cancers Discov. 2021;11:858–73.
Marrugo-Ramírez J, Mir M, Samitier J. Blood-based most cancers biomarkers in liquid biopsy: a promising non-invasive different to tissue biopsy. Int J Mol Sci. 2018;19:34.
Li Okay, Lin Y, Luo Y, Xiong X, Wang L, Durante Okay, Li J, Zhou F, Guo Y, Chen S, et al. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter potential examine. Mol Most cancers. 2022;21:21.
Nakano T, Chen IH, Wang CC, Chen PJ, Tseng HP, Huang KT, Hu TH, Li LC, Goto S, Cheng YF, et al. Circulating exosomal miR-92b: Its position for most cancers immunoediting and medical worth for prediction of posttransplant hepatocellular carcinoma recurrence. Am J Transplant. 2019;19:3250–62.
Aboulkheyr Es H, Montazeri L, Aref AR, Vosough M, Baharvand H. Customized most cancers drugs: an organoid method. Traits Biotechnol. 2018;36:358–71.
Richards T, Patel H, Patel Okay, Schanne F. Endogenous lipid carriers-bench-to-bedside roadblocks in manufacturing and drug loading of exosomes. Prescribed drugs (Basel). 2023;16:421.
Emam SE, Ando H, Abu Lila AS, Shimizu T, Ukawa M, Okuhira Okay, Ishima Y, Mahdy MA, Ghazy FS, Ishida T. A novel technique to extend the yield of exosomes (extracellular vesicles) for an growth of primary analysis. Biol Pharm Bull. 2018;41:733–42.
Busatto S, Vilanilam G, Ticer T, Lin WL, Dickson DW, Shapiro S, Bergese P, Wolfram J. Tangential move filtration for extremely environment friendly focus of extracellular vesicles from massive volumes of fluid. Cells. 2018;7:23.
Gandham S, Su X, Wooden J, Nocera AL, Alli SC, Milane L, Zimmerman A, Amiji M, Ivanov AR. Applied sciences and standardization in analysis on extracellular vesicles. Traits Biotechnol. 2020;38:1066–98.
Li D, Gong L, Lin H, Yao S, Yin Y, Zhou Z, Shi J, Wu Z, Huang Z. Hyaluronic acid-coated bovine milk exosomes for attaining tumor-specific intracellular supply of miRNA-204. Cells. 2022;11:12.
Ren C, Li Y, Cong Z, Li Z, Xie L, Wu S. Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder most cancers immune-modulatory chemotherapy. Entrance Immunol. 2023;14:1129771.
Xu Z, Xu Y, Zhang Okay, Liu Y, Liang Q, Thakur A, Liu W, Yan Y. Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human illness and therapeutic modalities. J Nanobiotechnology. 2023;21:114.
Kong L, Yang C, Zhang Z. Organism-generated organic vesicles in situ: an rising drug supply technique. Adv Sci (Weinh). 2023;10: e2204178.
Hussen BM, Faraj GSH, Rasul MF, Hidayat HJ, Salihi A, Baniahmad A, Taheri M, Ghafouri-Frad S. Methods to beat the primary challenges of using exosomes as drug service for most cancers remedy. Most cancers Cell Int. 2022;22:323.